The role of resveratrol for preventing the ovarian hyperstimulation syndrome
Phase 1
- Conditions
- Resveratrol may prevent the incidence of ovarian hyperstimulation syndrome by reducing the expression of VEGF and estradiol, improving the haemoconcentration and ascitis ReTherapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]
- Registration Number
- EUCTR2014-003986-11-ES
- Lead Sponsor
- IVI Madrid
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
Egg donors who meet the following criteria:
1. Number of follicles (>12 mm) > o = 21 in the last scan previous ovum pick-up.
2. Number of retrieved oocytes > o =21.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 70
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Exclusión criteria for egg donation: >35 years, polycystic ovary syndrome, endometriosis, severe systematic pathology, positive serologies for BHV, CHV o HIV, or altered karyotype.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method